Your browser doesn't support javascript.
loading
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
Vagrecha, Anshul; Stanco, Joseph; Majeed, Sumreen; Kouides, Peter; Acharya, Suchitra S.
Affiliation
  • Vagrecha A; Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.
  • Stanco J; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Majeed S; Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.
  • Kouides P; Northwell Health Cancer Institute, Imbert Cancer Center, Bay Shore, NY, USA.
  • Acharya SS; Mary M. Gooley Hemophilia Center, University of Rochester School of Medicine, Rochester, NY, USA.
Haemophilia ; 27(4): e517-e519, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33427345
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombosis / Heparin, Low-Molecular-Weight / Venous Thromboembolism / Von Willebrand Disease, Type 3 / COVID-19 / Anticoagulants Type of study: Etiology_studies Limits: Aged / Female / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombosis / Heparin, Low-Molecular-Weight / Venous Thromboembolism / Von Willebrand Disease, Type 3 / COVID-19 / Anticoagulants Type of study: Etiology_studies Limits: Aged / Female / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: United States